Upcoming Projects (CNAT)
Don’t see a project related to the company you care about? Create your own!
Executed Projects (CNAT)
Upcoming & Overdue Catalysts (CNAT)
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (CNAT)
FDA Grants Conatus Fast Track Designation for Development of Emricasan in liver cirrhosis caused by NASH
Occurred on: Feb 03, 2016
Conatus Achieves Positive Results with Emricasan in Initial Stage of Phase 2 Liver Cirrhosis Clinical Trial
Occurred on: Jan 05, 2016
Strategic Initiatives (CNAT)
Novartis (NVS) Agrees to Exclusive Worldwide License Agreement for Contaus Pharma's (CNAT) Orally Active Pan-Caspase Inhibitor Emricasan
Tickers: NVS, CNAT
Announcement Date: Dec 19, 2016